Depression, quality of life, and medical resource utilization in sickle cell disease

Blood Advances

Volumn 1, Issue 23, 2017, Pages 1983-1991

  Adam, Soheir S ^a,b   Flahiff, Charlene M ^a   Kamble, Shital ^c   Telen, Marilyn J ^a   Reed, Shelby D ^a,c   De Castro, Laura M ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85044250796     PISSN: 24739529     EISSN: 24739537     Source Type: Journal    
DOI: 10.1182/bloodadvances.2017006940     Document Type: Article

References (55)

1. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94-101.
2. Currie SR, Wang J. Chronic back pain and major depression in the general Canadian population. Pain. 2004;107(1-2):54-60.
3. Arnow BA, Hunkeler EM, Blasey CM, et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med. 2006;68(2):262-268.
4. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60(1):39-47.
5. Jenerette C, Funk M, Murdaugh C. Sickle cell disease: A stigmatizing condition that may lead to depression. Issues Ment Health Nurs. 2005;26(10): 1081-1101.
6. Comer EW. Integrating the health and mental health needs of the chronically ill: A group for individuals with depression and sickle cell disease. Soc Work Health Care. 2004;38(4):57-76.
7. Belgrave FZ, Molock SD. The role of depression in hospital admissions and emergency treatment of patients with sickle cell disease. J Natl Med Assoc. 1991;83(9):777-781.
8. Molock SD, Belgrave FZ. Depression and anxiety in patients with sickle cell disease: Conceptual and methodological considerations. J Health Soc Policy. 1994;5(3-4):39-53.
9. Hasan SP, Hashmi S, Alhassen M, Lawson W, Castro O. Depression in sickle cell disease. J Natl Med Assoc. 2003;95(7):533-537.
10. Leavell SR, Ford CV. Psychopathology in patients with sickle cell disease. Psychosomatics. 1983;24(1):23-25, 28-29, 32 passim.
11. Nadel C, Portadin G. Sickle cell crises: Psychological factors associated with onset. N Y State J Med. 1977;77(7):1075-1078.
12. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: The PiSCES project. Health Qual Life Outcomes. 2005; 3:50.
13. Schmidt WP, Roesler A, Kretzschmar K, Ladwig KH, Junker R, Berger K. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc. 2004;52(7):1045-1050.
14. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 1993;24(11):1631-1634.
15. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998;91(1):288-294.
16. Nunes S, Argollo N, Mota M, Vieira C, Sena EP. Comprehensive neuropsychological evaluation of children and adolescents with sickle cell anemia: A hospital-based sample. Rev Bras Hematol Hemoter. 2017;39(1):32-39.
17. Armstrong FD, Thompson RJ Jr, Wang W, et al; Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics. 1996;97(6 Pt 1):864-870.
18. Davis H, Moore RM Jr, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep. 1997;112(1): 40-43.
19. Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009; 84(6):323-327.
20. Luber MP, Hollenberg JP, Williams-Russo P, et al. Diagnosis, treatment, comorbidity, and resource utilization of depressed patients in a general medical practice. Int J Psychiatry Med. 2000;30(1):1-13.
21. Carroll PC, Haywood C Jr, Hoot MR, Lanzkron S. A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain. 2013;29(4):317-323.
22. Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA. Mental health disorders influence admission rates for pain in children with sickle cell disease. Pediatr Blood Cancer. 2013;60(7):1211-1214.
23. Jonassaint CR, Jones VL, Leong S, Frierson GM. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol. 2016;174(1):136-147.
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
25. Geisser ME, Roth RS, Robinson ME. Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: A comparative analysis. Clin J Pain. 1997;13(2):163-170.
26. Grant D, Almond MK, Newnham A, Roberts P, Hutchings A. The Beck Depression Inventory requires modification in scoring before use in a haemodialysis population in the UK. Nephron Clin Pract. 2008;110(1):c33-c38.
27. Hedayati SS, Bosworth HB, Kuchibhatla M, Kimmel PL, Szczech LA. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006;69(9):1662-1668.
28. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6): 473-483.
29. Alonso J, Ferrer M, Gandek B, et al; IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Qual Life Res. 2004;13(2):283-298.
30. Rijken M, van Kerkhof M, Dekker J, Schellevis FG. Comorbidity of chronic diseases: Effects of disease pairs on physical and mental functioning. Qual Life Res. 2005;14(1):45-55.
31. Wittink H, Turk DC, Carr DB, Sukiennik A, Rogers W. Comparison of the redundancy, reliability, and responsiveness to change among SF-36, Oswestry Disability Index, and Multidimensional Pain Inventory. Clin J Pain. 2004;20(3):133-142.
32. Dampier C, Lieff S, LeBeau P, et al; Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium (CTC). Health-related quality of life in children with sickle cell disease: A report from the Comprehensive Sickle Cell Centers Clinical Trial Consortium. Pediatr Blood Cancer. 2010;55(3):485-494.
33. Asnani MR, Lipps GE, Reid ME. Validation of the SF-36 in Jamaicans with sickle-cell disease. Psychol Health Med. 2009;14(5):606-618.
34. Afenyi-Annan A, Kail M, Combs MR, Orringer EP, Ashley-Koch A, Telen MJ. Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease. Transfusion. 2008;48(5):917-924.
35. Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Arch Clin Neuropsychol. 2006;21(7): 623-643.
36. ASPE (Office of the Assistant Secretary for Planning and Evaluation). Computations for the 2009 Annual Update of the HHS Poverty Guidelines for the 48 Contiguous States and the District of Columbia. Washington, DC: U.S. Department of Health and Human Services; 2009.
37. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: The PiSCES project. Psychosom Med. 2008;70(2): 192-196.
38. Gil KM, Abrams MR, Phillips G, Keefe FJ. Sickle cell disease pain: Relation of coping strategies to adjustment. J Consult Clin Psychol. 1989;57(6): 725-731.
39. Conyard S, Krishnamurthy M, Dosik H. Psychosocial aspects of sickle-cell anemia in adolescents. Health Soc Work. 1980;5(1):20-26.
40. Hurtig AL, White LS. Psychosocial adjustment in children and adolescents with sickle cell disease. J Pediatr Psychol. 1986;11(3):411-427.
41. McCrae JD, Lumley MA. Health status in sickle cell disease: Examining the roles of pain coping strategies, somatic awareness, and negative affectivity. J Behav Med. 1998;21(1):35-55.
42. Thompson RJ Jr, Gil KM, Abrams MR, Phillips G. Stress, coping, and psychological adjustment of adults with sickle cell disease. J Consult Clin Psychol. 1992;60(3):433-440.
43. Elander J, Midence K. A review of evidence about factors affecting quality of pain management in sickle cell disease. Clin J Pain. 1996;12(3):180-193.
44. SAMHSA (Substance Abuse and Mental Health Services Administration). Results from the 2012 National Survey on Drug Use and Health: Mental Health Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
45. Bjørngaard JH, Carslake D, Lund Nilsen TI, et al. Association of body mass index with depression, anxiety and suicide: An instrumental variable analysis of the HUNT study. PLoS One. 2015;10(7):e0131708.
46. Baumeister H, Härter M. Mental disorders in patients with obesity in comparison with healthy probands. Int J Obes. 2007;31(7):1155-1164.
47. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: A systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220-229.
48. Daly EJ, Trivedi MH, Wisniewski SR, et al. Health-related quality of life in depression: A STAR*D report. Ann Clin Psychiatry 2010;22(1):43-55.
49. Dampier C, LeBeau P, Rhee S, et al; Comprehensive Sickle Cell Centers (CSCC) Clinical Trial Consortium (CTC) Site Investigators. Health-related quality of life in adults with sickle cell disease (SCD): A report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol. 2011; 86(2):203-205.
50. Mastandréa EB, Lucchesi F, Kitayama MM, Figueiredo MS, Citero VA. The relationship between genotype, psychiatric symptoms and quality of life in adult patients with sickle cell disease in São Paulo, Brazil: A cross-sectional study. Sao Paulo Med J. 2015;133(5):421-427.
51. Graves JK, Hodge C, Jacob E. Depression, anxiety, and quality of life in children and adolescents with sickle cell disease. Pediatr Nurs. 2016;42(3): 113-119, 144.
52. Dias FLDC, Teixeira AL, Guimarães HC, et al. Cognitive performance of community-dwelling oldest-old individuals with major depression: The Piet à study. Int Psychogeriatr. 2017;29(9):1507-1513.
53. Davis MT, DellaGioia N, Matuskey D, et al. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures. J Affect Disord. 2017;218:82-85.
54. Lanzkron S, Haywood C Jr, Segal JB, Dover GJ. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol. 2006;81(12):927-932.
55. Taheri PA, Butz DA, Greenfield LJ. Length of stay has minimal impact on the cost of hospital admission. J Am Coll Surg. 2000;191(2):123-130.